Publication:

The VEGFR inhibitor cediranib improves the efficacy of fractionated radiotherapy in a colorectal cancer xenograft model

Date

 
dc.contributor.authorMelsens, Elodie
dc.contributor.authorVerberckmoes, Bert
dc.contributor.authorRosseel, Natacha
dc.contributor.authorVanhove, Christian
dc.contributor.authorDescamps, Benedicte
dc.contributor.authorPattyn, Piet
dc.contributor.authorCeelen, Wim
dc.date.accessioned2021-10-24T09:07:07Z
dc.date.available2021-10-24T09:07:07Z
dc.date.issued2017
dc.identifier.issn1421-9921
dc.identifier.urihttps://imec-publications.be/handle/20.500.12860/28961
dc.identifier.urlhttps://www.karger.com/Article/Abstract/452741
dc.source.beginpage95
dc.source.endpage108
dc.source.issue3_4
dc.source.journalEuropean Surgical Research
dc.source.volume58
dc.title

The VEGFR inhibitor cediranib improves the efficacy of fractionated radiotherapy in a colorectal cancer xenograft model

dc.typeJournal article
dspace.entity.typePublication
Files
Publication available in collections: